temporarily. For private investments, that decreased from the same period of last year in all sectors from instability of the economy, except for ongoing projects of improvement, maintenance and automation
lockdown in many countries around the world including Thailand. But the negative impact on domestic consumption, manufacturing and export sectors persisted in this quarter, despite improvement from the
December 2018 stood at 0.55x, an improvement from 0.93x in 31 December 2017. Current ratio as of the same date and period stood at 2.67x, a considerable improvement from 1.69x, both mainly as a result of the
for long term growth, while remaining focused on supporting, supplementing and leveraging our flagship business of Combined PET. • With the reopening of economies, easing of lockdowns and improvement in
in Asia. Overall Sales have increased despite lockdown in various countries with COVID19 reinforcing essentials nature of our business. Lower oil prices have led to an improvement in earnings of our
management and the SDGs into decision-making, fill gaps in current market practices which are undermining progress towards the SDGs, and connect different actors across the ecosystem to create the enabling
change in net working capital and cash tax, before maintenance capex Indorama Ventures 2nd Quarter 2019 MD&A 3 Summary 2Q19 results IVL’s performance for the first half and ongoing progress give us the
%, driven by structural improvement in the commodity cycle and strong demand across geographies. Core EBITDA per ton of $139, up 32% YoY, driven by uptrend in PET margins and significant recovery in Asia
.............................................................................................................................................................. 15 3.3. Pathway 2: Relative Performance Improvement ................................................................................................................................................. 16
final blueprint Example Project A progress % billing % Q3’20 10 - Q3’20 20 - Q4’20 15 10 Q4’20 35 20 Q1’21 20 50 Q2’21 - 20 100 100The entity measures progress according to % billing recognise revenue 99